Current notice

To support the measures to contain the coronavirus, our office is currently only staffed to a limited extent. Visits are not possible at the moment. However, our employees can be reached by phone and e-mail during office hours.

 

Technology Transfer for the Max Planck Society

Max Planck Innovation is responsible for technology transfer from the research institutes of the Max Planck Society.

The Max Planck Society (MPG) operates as Germany’s most successful organization in basic research and is worldrenowned for its cutting-edge research. In many cases this cutting-edge research also forms the basis for innovative products and services that are implemented through licensing and spin-off companies.

Thus we perform an important task: the transfer of basic research results into products, which contribute to the economic and social progress.

50 years of Max Planck innovation - 50 years of technology transfer for the Max Planck Society

Max Planck Innovation celebrates its 50th anniversary. On this occasion, MaxPlanckResearch reports on success stories, researchers and founders, companies, perspectives and the path from ideas to products.

eMagazine

Download as PDF (6,9 MB)

We are your contact for

Invention

We advise and support scientists in the evaluation and patenting of research results while helping to establish the best success in the market.

More

Foundation

Do you have a business idea? If so, talk to us! We offer founders a comprehensive range of services from evaluating a spin-off project through to fundraising support.

More

Industry

We provide future-oriented companies with access to the patented inventions and know-how of the Max Planck Institutes and offer them licensing opportunities.

More

Technology Offers

Sensors, Devices & Components

Multifunctional RFID-based Platform for Animal Observation and Manipulation

Go to techoffer

New Materials

Bioinspired Liquid-Superrepellent Fibrillar Dry Adhesives

Go to techoffer

Analytics

Novel method for analysis of complex carbohydrate structures by ion-mobility mass spectrometry (IM-MS)

Go to techoffer

IT / Software / Bioinformatics

Novel protein expression optimization method combining machine learning with insights from mechanistic modelling of mRNA translation

Go to techoffer

Processes and Methods

High-precision base editors for site-specific single nucleotide conversion

Go to techoffer

Medicine

First in class “semi-live” RNA vaccines against SARS-CoV-2, RSV and other respiratory viruses

Go to techoffer

Research Tools

A novel type of influenza A virus-derived Defective interfering Particle for antiviral therapy

Go to techoffer

Imaging & Microscopy

Method for the Calibration of a Microscope Setup

Go to techoffer

News

Press release

License

Midbrain organoids for automated chemical screening and disease research

More

Press release

Acquisition

Cellink acquires MPG spin-off Scienion AG for 80 million euros

More

Press release

Start-up QLi5

Development of novel proteasome inhibitors for treating cancer, inflammatory and autoimmune disorders

More

Press release

Clinical Study

Drug candidate for cancer immunotherapy enters Phase I study

More

Press release

Funding

Scientists are developing a procedure whereby vaccines can be absorbed through the skin

More

Press release

Clinical Study

New treatment method for curing HIV being tested in clinical study

More

Press release

Yearbook 2019

Patents, spin-off companies and license agreements

More

 

Press release

Funding

Quench Bio closes $ 50M series A financing to advance first-in-class medicines against severe inflammatory diseases

More

 

Newsletter Sign up

Sign up for our newsletter and our press releases and receive the latest information on technology transfer from the Max Planck Society: Sign up